Medical therapy versus percutaneous coronary intervention in ischemic heart disease: A cost-effectiveness analysis

Cost-Effectiveness Analysis of Rapid Test Compared to Polymerase Chain Reaction (PCR) in Patients with Acute Respiratory Syndrome

“…In this study, for cost-effectiveness analysis, after drawing the decision tree model in the TreeAge pro 2011 software, the ICER was calculated and the WHO approach was used to calculate the cost-effectiveness threshold so that if the incremental cost-effectiveness ratio is less than three times the GDP per capita, the strategy is costeffective (20,21). An ICER is calculated by dividing the difference in total costs (incremental cost) by the difference in the chosen measure of health outcome (incremental effect) (18,22).…”

Economic Burden of Epidermolysis Bullosa Disease in Iran

“…Also knowing the costs of a disease can help policymakers decide which disease should be considered as the first disease by prevention with health care policies. In addition, these studies can indicate which treatments for the disease can be helpful in reducing the economic burden of the disease ( 15 - 17 ).…”